Indraprastha Medical Corporation Limited (INDRAMEDCO) Stock Statistics & Valuation Metrics

Indraprastha Medical Corporation Limited has a market cap or net worth of ₹36.93B. The enterprise value is ₹36.37B.

Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Indraprastha Medical Corporation Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Indraprastha Medical Corporation Limited is ―. Indraprastha Medical Corporation Limited’s PEG ratio is ―.

In the last 12 months, Indraprastha Medical Corporation Limited had revenue of 12.45B and earned 1.24B in profits. Earnings per share was 13.52.

In the last 12 months, operating cash flow was 401.20M and capital expenditures 0.00, giving a free cash flow of 401.20M billion.

Indraprastha Medical Corporation Limited pays an annual dividend of ₹4.5, resulting in a dividend yield of 1.07%

Indraprastha Medical Corporation Limited upcoming earnings date is May 22, 2025, TBA Not Confirmed.

Indraprastha Medical Corporation Limited as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Indraprastha Medical Corporation Limited has paid 421.50M in taxes.

Indraprastha Medical Corporation Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Indraprastha Medical Corporation Limited has ₹2.24B in cash and marketable securities with ₹212.90M in debt, giving a net cash position of -₹2.24B billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Indraprastha Medical Corporation Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―